1. Yang, Biwei, Li, Meiyi, Tang, Wenqing, Chen, Luonan, Xia, Jinglin. 2018. Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma. In Nature communications, 9, 678. doi:10.1038/s41467-018-03024-2. https://pubmed.ncbi.nlm.nih.gov/29445139/
2. Zhang, Heng, Wang, Shao-Qiang, Zhu, Jie-Bo, Duan, Chao-Jun, Zhang, Chun-Fang. 2023. LncRNA CALML3-AS1 modulated by m6A modification induces BTNL9 methylation to drive non-small-cell lung cancer progression. In Cancer gene therapy, 30, 1649-1662. doi:10.1038/s41417-023-00670-7. https://pubmed.ncbi.nlm.nih.gov/37884580/
3. Sun, Mengjie, Li, Suyun, Ning, Feng, Duan, Haiping, Wu, Yili. 2022. Association between olfactory pathway gene variants and obesity in Chinese Han population: A case-control study based on genetic score. In Gene, 825, 146442. doi:10.1016/j.gene.2022.146442. https://pubmed.ncbi.nlm.nih.gov/35337849/
4. Nie, Tingting, Zhang, Chengqiang, Zhang, Gailian, Cui, Luping, Wang, Jie. 2021. LncRNA CALML3-AS1 regulates chondrocyte apoptosis by acting as a sponge for miR-146a. In Autoimmunity, 54, 336-342. doi:10.1080/08916934.2021.1943663. https://pubmed.ncbi.nlm.nih.gov/34282692/
5. Zhang, Xiaozhou, Zhang, Xiaojian, Jia, Qian, Jiang, Nannan, Yin, Detao. 2022. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. In BMC cancer, 22, 344. doi:10.1186/s12885-022-09360-3. https://pubmed.ncbi.nlm.nih.gov/35351042/
6. Mao, Guangxian, Liu, Jixian. 2024. CALML3-AS1 enhances malignancies and stemness of small cell lung cancer cells through interacting with DAXX protein and promoting GLUT4-mediated aerobic glycolysis. In Toxicology and applied pharmacology, 495, 117177. doi:10.1016/j.taap.2024.117177. https://pubmed.ncbi.nlm.nih.gov/39617259/
智鼠故事 
